Study to assess oral IPN60130 for the treatment | Clinical Research Studies Listing

Build status - In Progress

Recruiting

5 years - 99 years

All

Phase 2

10 participants needed

1 Location

Brief description of study

The purpose of this study is to investigate the safety and efficacy of an investigational drug called IPN60130 in the treatment of FOP. IPN60130 is considered “investigational” because it has not been approved by the United States Food and Drug Administration (U.S. FDA) for the treatment of FOP.

Detailed description of study

There are two parts of this study, Part A and Part B. In Part A, you could receive a high or low dose of IPN60130 or placebo as 1-4 capsules based on your weight. The placebo will look like IPN60130 but will not contain any active ingredients. After completing Part A, all participants will continue into Part B and receive IPN60130. If you were receiving IPN60130 in Part A you will continue with the same dose. If you were receiving placebo in Part A you will be assigned to receive one of the 2 doses of IPN60130. You will not know which treatment you will be receiving nor the study doctor. This is called being blinded to the treatment. Your overall participation in this study (both Part A and Part B) will last up to 26 months. Your participation will involve visits to the study site and may also involve visits at your home by a home care nurse.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research, Fibrodysplasia Ossificans Progressiva, FOP
Age: 5 years - 99 years
Gender: All

Diagnosed with Fibrodysplasia Ossificans Progressiva (FOP)

Updated on 04 Aug 2024. Study ID: 844711

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.